Rymbai, M., and V. V. Borah. “Impact of the Revised CLSI M100 (36th Edition, 2026) Minimum Inhibitory Concentration Breakpoints on Antimicrobial Susceptibility Interpretation and Multidrug-Resistance Classification of Clinical Pseudomonas Aeruginosa Isolates: A Retrospective Study”. International Journal of Basic & Clinical Pharmacology, vol. 15, no. 5, Aug. 2026, pp. 1002-9, doi:10.18203/2319-2003.ijbcp20262873.